Repeat-positive SARS-CoV-2 in a child with cancer.
作者信息
Radhakrishnan Venkatraman, Gangopadhyay Devleena
机构信息
Department of Medical Oncology (Pediatric Oncology Division), Cancer Institute (WIA), Adyar, Chennai, India.
出版信息
Pediatr Blood Cancer. 2021 Mar;68(3):e28744. doi: 10.1002/pbc.28744. Epub 2020 Oct 3.
Abstract
摘要
相似文献
1
Repeat-positive SARS-CoV-2 in a child with cancer.一名癌症患儿出现新冠病毒重复阳性情况。
Pediatr Blood Cancer. 2021 Mar;68(3):e28744. doi: 10.1002/pbc.28744. Epub 2020 Oct 3.
2
SARS-CoV-2 infection in a 7-year-old girl with pancytopenia during acute lymphocytic leukemia maintenance therapy.一名7岁女童在急性淋巴细胞白血病维持治疗期间出现全血细胞减少并感染了新冠病毒。
Pediatr Blood Cancer. 2020 Nov;67(11):e28391. doi: 10.1002/pbc.28391. Epub 2020 Aug 11.
3
6-mercaptopurine: efficacy and bone marrow toxicity in childhood acute lymphoblastic leukemia. Association with low (thio)purine enzyme activity.6-巯基嘌呤：儿童急性淋巴细胞白血病的疗效与骨髓毒性。与低（硫）嘌呤酶活性的关联。
Adv Exp Med Biol. 2000;486:271-5. doi: 10.1007/0-306-46843-3_53.
4
Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia.转运蛋白基因多态性对急性淋巴细胞白血病患儿维持治疗剂量、疗效及毒性的影响。
Gene. 2017 Sep 10;628:72-77. doi: 10.1016/j.gene.2017.07.025. Epub 2017 Jul 12.
5
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity.大剂量甲氨蝶呤治疗儿童急性白血病后的骨髓毒性受6-巯基嘌呤剂量影响，但不受硫嘌呤甲基转移酶中间活性影响。
Cancer Chemother Pharmacol. 2015 Jan;75(1):59-66. doi: 10.1007/s00280-014-2613-7. Epub 2014 Oct 28.
6
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.地塞米松与泼尼松对比以及每日口服与每周静脉注射巯嘌呤治疗标准风险急性淋巴细胞白血病患者：儿童癌症研究组的报告
Blood. 2003 May 15;101(10):3809-17. doi: 10.1182/blood-2002-08-2454. Epub 2003 Jan 16.
7
Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.急性淋巴细胞白血病患儿叶酸代谢酶的基因多态性与高剂量甲氨蝶呤的毒性
Ann Hematol. 2007 Aug;86(8):609-11. doi: 10.1007/s00277-007-0274-x. Epub 2007 Feb 24.
8
[Radiological case of the month. Leukoencephalopathy caused by methotrexate in a child treated for acute lymphoblastic leukemia].[本月放射病例。一名接受急性淋巴细胞白血病治疗的儿童因甲氨蝶呤导致的白质脑病]
Arch Pediatr. 1996 Jan;3(1):85-7. doi: 10.1016/s0929-693x(96)80016-9.
9
The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX).6-巯基嘌呤（6-MP）与甲氨蝶呤（MTX）的相互作用。
Gen Pharmacol. 1999 Oct;33(4):341-6. doi: 10.1016/s0306-3623(99)00022-1.
10
Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.一名急性淋巴细胞白血病患儿在接受高剂量甲氨蝶呤治疗后反复出现白质脑病发作。
Indian Pediatr. 2017 Feb 15;54(2):159.
引用本文的文献
1
Impact of COVID-19 on clinical outcomes and care delivery in pediatric oncology patients in Lebanon in 2020-2023: a retrospective study.2020 - 2023年新冠疫情对黎巴嫩儿科肿瘤患者临床结局及医疗服务的影响：一项回顾性研究
Front Pediatr. 2025 Jul 9;13:1608740. doi: 10.3389/fped.2025.1608740. eCollection 2025.
2
COVID-19 infection in children with blood cancer: A systematic review.血癌患儿的新冠病毒感染：一项系统综述
Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5.
3
COVID-19 in Children and Adolescents: Characteristics and Specificities in Immunocompetent and Oncohematological Patients.儿童和青少年中的COVID-19：免疫功能正常和肿瘤血液学患者的特征及特异性
Mediterr J Hematol Infect Dis. 2022 Jan 1;14(1):e2022009. doi: 10.4084/MJHID.2022.009. eCollection 2022.
4
Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.儿童癌症与 COVID-19 患者的临床表现和结局：一项系统综述。
Pediatr Blood Cancer. 2021 Jun;68(6):e29005. doi: 10.1002/pbc.29005. Epub 2021 Mar 15.
5
Asymptomatic reactivation of SARS-CoV-2 in a child with neuroblastoma characterised by whole genome sequencing.通过全基因组测序表征的神经母细胞瘤患儿中SARS-CoV-2的无症状再激活。
IDCases. 2021;23:e01018. doi: 10.1016/j.idcr.2020.e01018. Epub 2020 Dec 3.
本文引用的文献
1
Clinical Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in the Republic of Korea.韩国 2019 年冠状病毒病患儿的临床特征和病毒 RNA 检测
JAMA Pediatr. 2021 Jan 1;175(1):73-80. doi: 10.1001/jamapediatrics.2020.3988.
2
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR.经 RT-PCR 检测 SARS-CoV-2 再次呈阳性的 COVID-19 患者的临床、免疫学和病毒学特征。
EBioMedicine. 2020 Sep;59:102960. doi: 10.1016/j.ebiom.2020.102960. Epub 2020 Aug 24.
3
Re-positive coronavirus disease 2019 PCR test: could it be a reinfection?新型冠状病毒肺炎核酸检测复阳：这会是再次感染吗？
New Microbes New Infect. 2020 Sep;37:100748. doi: 10.1016/j.nmni.2020.100748. Epub 2020 Aug 20.
4
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.2019 年冠状病毒病（COVID-19）通过全基因组测序确认为与严重急性呼吸综合征冠状病毒 2 株系不同的病毒再次感染。
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951. doi: 10.1093/cid/ciaa1275.
5
Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results.新型冠状病毒 2019 年是否可能再次感染？解读动态 SARS-CoV-2 检测结果。
Am J Emerg Med. 2021 Jan;39:256.e1-256.e3. doi: 10.1016/j.ajem.2020.06.079. Epub 2020 Jul 4.
6
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.SARS-CoV-2 RNA 脱落持续时间及 COVID-19 患者病毒脱落时间延长的相关因素。
J Med Virol. 2021 Jan;93(1):506-512. doi: 10.1002/jmv.26280. Epub 2020 Jul 15.
7
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review.粪便中 SARS-CoV-2 的持续病毒脱落——快速综述。
Colorectal Dis. 2020 Jun;22(6):611-620. doi: 10.1111/codi.15138. Epub 2020 Jun 4.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
Zotero 插件